logo
Should public health bodies stop commissioning research from market research companies that serve the tobacco industry?
Is research in substance abuse undervalued?
Addiction Research Centres and the Nurturing of Creativity
Conversation with Connie Weisner
Retention of participants in medication-assisted programs in low- and middle-income countries: an international systematic review
Commentary on Freelemyer et al . (2014): Medication-assisted treatment in Africa—need is growing but response remains tepid
A systematic review of studies assessing the association between adherence to smoking cessation medication and treatment success
Acute alcohol-related dysfunction as a predictor of employment status in a longitudinal study of working-age men in Izhevsk, Russia
Legalization of Sunday alcohol sales and alcohol consumption in the United States
Chronic hepatitis C virus infection is associated with all-cause and liver-related mortality in a cohort of HIV-infected patients with alcohol problems
Usefulness of indirect alcohol biomarkers for predicting recidivism of drunk-driving among previously convicted drunk-driving offenders: results from the Recidivism Of Alcohol-impaired Driving (ROAD) study
Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial
Commentary on Hser et al. (2014): To retain or not to retain—open questions in opioid maintenance therapy
Causes of death in a cohort treated for opioid dependence between 1985 and 2005
Commentary on Degenhardt et al. (2014): Cohort studies enhance the picture of drug-related deaths
Non-medical use of prescription opioids during the transition to adulthood: a multi-cohort national longitudinal study
The relationship between cannabis outcome expectancies and cannabis refusal self-efficacy in a treatment population
A closer look at the evidence for sex differences in the genetic and environmental influences on gambling in the National Longitudinal Study of Adolescent health: from disordered to ordered gambling
Pharmacotherapy effects on smoking cessation vary with nicotine metabolism gene ( CYP2A6)
Commentary on Chen et al. (2014): Another step on the road to clinical utility of pharmacogenetics for smoking cessation?
Impact of the 2009 Taiwan Tobacco Hazards Prevention Act on Smoking Cessation
Did hardening occur among smokers in England from 2000 to 2010?
Tobacco use disorder and the risk of suicide mortality
A second-class science? A defence of observational epidemiology to make causal inferences
Second-class evidence for causality, not second-class science
News and Notes